Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release
Cencora (NYSE: COR) has scheduled its First Quarter Fiscal 2025 earnings release for Wednesday, February 5, 2025, before the NYSE opening bell. The company will host a conference call at 8:30 a.m. ET the same day, featuring President & CEO Robert P. Mauch and CFO James F. Cleary.
The earnings call will be accessible via webcast on investor.cencora.com and by telephone. U.S. and Canada participants can dial (833) 470-1428, while international callers should use +1 (404) 975-4839, with access code 427679. Replays will be available on the website and via telephone for 7 days using the access code 402593.
Cencora is a global pharmaceutical solutions organization ranked #10 on the Fortune 500 and #18 on the Global Fortune 500, generating over $290 billion in annual revenue. The company employs 46,000+ team members worldwide.
Cencora (NYSE: COR) ha programmato la comunicazione dei risultati del primo trimestre fiscale 2025 per mercoledì 5 febbraio 2025, prima della campanella di apertura della NYSE. L'azienda ospiterà una conferenza telefonica alle 8:30 ET lo stesso giorno, con il Presidente e CEO Robert P. Mauch e il CFO James F. Cleary.
La teleconferenza sarà accessibile tramite webcast su investor.cencora.com e per telefono. I partecipanti dagli Stati Uniti e dal Canada possono chiamare il numero (833) 470-1428, mentre i chiamanti internazionali devono utilizzare +1 (404) 975-4839, con il codice di accesso 427679. Le ripetizioni saranno disponibili sul sito web e per telefono per 7 giorni utilizzando il codice di accesso 402593.
Cencora è un'organizzazione globale di soluzioni farmaceutiche classificata al numero 10 nella Fortune 500 e al numero 18 nella Global Fortune 500, generando oltre 290 miliardi di dollari di fatturato annuo. L'azienda impiega oltre 46.000 membri del team in tutto il mondo.
Cencora (NYSE: COR) ha programado la publicación de sus resultados del primer trimestre fiscal 2025 para miércoles 5 de febrero de 2025, antes de la campanada de apertura de la NYSE. La compañía llevará a cabo una conferencia telefónica a las 8:30 a.m. ET el mismo día, con el Presidente y CEO Robert P. Mauch y el CFO James F. Cleary.
La llamada de resultados estará disponible a través de webcast en investor.cencora.com y por teléfono. Los participantes de EE. UU. y Canadá pueden marcar (833) 470-1428, mientras que los que llaman internacionalmente deben usar +1 (404) 975-4839, con el código de acceso 427679. Las repeticiones estarán disponibles en el sitio web y por teléfono durante 7 días usando el código de acceso 402593.
Cencora es una organización global de soluciones farmacéuticas clasificada en el puesto 10 de la Fortune 500 y en el puesto 18 de la Global Fortune 500, generando más de 290 mil millones de dólares en ingresos anuales. La empresa emplea a más de 46,000 miembros del equipo en todo el mundo.
Cencora (NYSE: COR)는 2025년 2월 5일 수요일에 뉴욕 증권 거래소(NYSE) 개장 전에 2025 회계년도 1분기 실적 발표를 예정하고 있습니다. 이날 8:30 AM ET에 회장 겸 CEO인 Robert P. Mauch와 CFO인 James F. Cleary가 참석하는 컨퍼런스 콜을 개최합니다.
실적 발표 전화 회의는 investor.cencora.com에서 웹캐스트로 청취할 수 있으며, 전화로도 참여 가능합니다. 미국 및 캐나다 참가자는 (833) 470-1428로 전화할 수 있으며, 국제 전화자는 +1 (404) 975-4839로 전화하고 액세스 코드 427679를 입력해야 합니다. 다시 듣기는 7일 동안 웹사이트와 전화로 제공되며, 액세스 코드 402593를 사용합니다.
Cencora는 Fortune 500에서 10위, Global Fortune 500에서 18위의 글로벌 제약 솔루션 조직으로, 연간 수익이 2,900억 달러 이상입니다. 이 회사는 전 세계에 46,000명 이상의 팀원을 고용하고 있습니다.
Cencora (NYSE: COR) a prévu la publication de ses résultats du premier trimestre de l'exercice 2025 pour mercredi 5 février 2025, avant la cloche d'ouverture de la NYSE. L'entreprise organisera une conférence téléphonique à 8h30 ET le même jour, avec le Président et CEO Robert P. Mauch et le CFO James F. Cleary.
La conférence téléphonique sera accessible via webcast sur investor.cencora.com et par téléphone. Les participants des États-Unis et du Canada peuvent composer le numéro (833) 470-1428, tandis que les appelants internationaux doivent utiliser +1 (404) 975-4839, avec le code d'accès 427679. Les rediffusions seront disponibles sur le site web et par téléphone pendant 7 jours avec le code d'accès 402593.
Cencora est une organisation mondiale de solutions pharmaceutiques classée au 10ème rang du Fortune 500 et au 18ème rang du Global Fortune 500, générant plus de 290 milliards de dollars de revenus annuels. L'entreprise emploie plus de 46 000 membres dans le monde entier.
Cencora (NYSE: COR) hat die Veröffentlichung der Ergebnisse für das erste Quartal des Geschäftsjahres 2025 für Mittwoch, den 5. Februar 2025, vor der Eröffnungsglocke der NYSE angesetzt. Das Unternehmen wird am selben Tag um 8:30 Uhr ET eine Telefonkonferenz veranstalten, an der Präsident und CEO Robert P. Mauch sowie CFO James F. Cleary teilnehmen werden.
Der Gewinnaufruf wird über eine Webcast unter investor.cencora.com und telefonisch zugänglich sein. Teilnehmer aus den USA und Kanada können die Nummer (833) 470-1428 wählen, während internationale Anrufer +1 (404) 975-4839 verwenden sollten, mit dem Zugangscode 427679. Aufzeichnungen sind auf der Website und telefonisch für 7 Tage mit dem Zugangscode 402593 verfügbar.
Cencora ist eine globale Organisation für pharmazeutische Lösungen, die auf Platz 10 der Fortune 500 und auf Platz 18 der Global Fortune 500 eingestuft wird und jährlich über 290 Milliarden Dollar Umsatz erwirtschaftet. Das Unternehmen beschäftigt über 46.000 Teammitglieder weltweit.
- Fortune 500 ranking (#10) and Global Fortune 500 (#18) positions indicate strong market presence
- Substantial annual revenue exceeding $290 billion
- Large workforce of 46,000+ employees globally
- None.
Participating in the conference call will be:
Robert P. Mauch, President & Chief Executive Officer
James F. Cleary, Executive Vice President & Chief Financial Officer
The live call will be webcast via the Company’s website at investor.cencora.com. Users are encouraged to log on to the webcast approximately 10 minutes in advance of the scheduled start time of the call.
To access the call via telephone from within
Replays of the call will be made available via telephone and webcast. A replay of the webcast will be posted on investor.cencora.com approximately one hour after the completion of the call and will remain available for one year. The telephone replay will also be available approximately one hour after the completion of the call and will remain available for 7 days. To access the telephone replay from within
Please check the website investor.cencora.com for updates regarding the timing of the live webcasts and for replay information.
About Cencora
Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. Cencora partners with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on Cencora for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Cencora’s 46,000+ worldwide team members contribute to positive health outcomes through the power of Cencora’s purpose: Cencora is united in its responsibility to create healthier futures. Cencora is ranked #10 on the Fortune 500 and #18 on the Global Fortune 500 with more than
View source version on businesswire.com: https://www.businesswire.com/news/home/20250107768923/en/
Bennett S. Murphy
Senior Vice President, Head of Investor Relations and Treasury
Bennett.Murphy@cencora.com
Source: Cencora
FAQ
When will Cencora (COR) release its Q1 2025 earnings?
How can investors access Cencora's (COR) Q1 2025 earnings call?
What is Cencora's (COR) annual revenue?
What is Cencora's (COR) position on the Fortune 500?
How long will Cencora's (COR) Q1 2025 earnings call replay be available?
